ICOS Capital invests in Mevaldi B.V., a producer of cost-effective, bio-based chemical building blocks, to support its further industrial scale up and commercial roll-out

Mevaldi is a biotech company and pioneer in the field of building blocks for sustainable polymers and polyurethanes made from natural biological raw materials. Since 2020, the company has been developing 3MPD: an innovative product derived from sugars and wood residues, produced through a patented bio-thermochemical process. Mevaldi makes materials with high performance, low environmental impact, and a competitive price – with the entire production chain located within Europe. In this way, Mevaldi contributes competitively to the EU’s strategic autonomy, circular economy, and climate objectives.

The financing by ICOS Capital provides Mevaldi with additional resources to accelerate its industrial scale-up and commercial roll-out activities, aimed at providing the market with affordable chemical building blocks for a wide range of sustainable chemicals and applications. Mevaldi fits ICOS Capital’s strategy as it is ready to scale-up in a capital-efficient manner, and accelerates sustainability with breakthrough solutions that are cost-efficient, have clear market traction and proven scalability. ICOS Capital joins Mevaldi with High-Tech Gründerfonds (HTGF) and ICIG Ventures (ICIG), both from Germany.

HTGF is one of the leading and most active early-stage investors in Germany and Europe. Fund investors include the Federal Ministry for Economic Affairs and Energy, KfW Capital, and 45 companies and family offices. HTGF provides capital, expertise and strong networks to support founders in turning innovative ideas into international market leaders. The fund strengthens the technological backbone of Germany and Europe.

ICIG Ventures is the venture capital arm of International Chemical Investors Group (ICIG), investing in early-stage ventures in industrial biotechnology, chemistry, materials, energy, and food/agriculture to drive strategic innovation for the larger group’s chemical platforms, focusing on bio-based solutions, advanced materials, and process efficiency.

Peter van Gelderen, General Partner of ICOS, quotes: “We are very pleased to invest in Mevaldi given it’s attractive, CAPEX light scale-up trajectory and relatively straightforward road to multiple markets. With the current consortium of strong industrial partners with existing chemical production facilities where Mevaldi’s green chemical building blocks can be produced at an attractive cost price, already at relatively low scale.”

Roger Ottenheym, CEO Mevaldi, adds: “Next to HTGF and ICIG Ventures, we are proud to bring another strong investor with industrial mindset, and backing from the chemical and bio-based industries, to our shareholder base. We are working to rapidly scale and bring to market several bio-based building blocks that can be applied in existing, as well as new applications. We believe that our sustainable competitive edge and contribution to CO2 emissions reduction, at cost parity with fossil alternatives, will allow us to build a strong market position. We look forward to working with ICOS, providing us with financing, strategic insight, hands-on support and access to their industry network.”

Source

HTGF – High-Tech Gründerfonds, press release, 2026-01-13.

Supplier

Bundesministerium für Wirtschaft und Energie - BMWE
High-Tech Gründerfonds Management GmbH (HGTF)
Icos Capital
International Chemical Investors Group ICIG
Mevaldi

Share